Evrys Bio’s CEO Lillian Chiang to address NIH SARS-CoV-2 Antiviral Therapeutics Summit

Evrys Bio’s CEO Lillian Chiang will address the topic “Are there broad spectrum modalities for targeting SARS-CoV-2 that could be useful against other viruses and thus for future pandemic response?” at the upcoming NIH Symposium scheduled for Friday, November 6, 2020
11:00 AM – 3:30 PM Eastern Time